Chief Executive Officer
Dr Enderling has broad industry experience and has worked in both healthcare and energy markets. After starting his career as an engineer, Stefan spent 5 years as Business Development Manager with TechInSA, a seed investment organisation focused on the biotechnology and medical devices sectors. During his time there he identified, assessed and enabled multimillion dollar funding for small to medium sized technology companies. Following his time at TechInSA he became General Manager of Australian based Jackson Care Technologies Pty Ltd, where he built and commercialised a new smart support assistive technology product from the ground up. Stefan was seconded to Anteo where he assisted with business plan development, the identification of several potential international commercial partners and the initiation of discussions with those potential partners, to progress the license or sale of the Company’s Lithium-ion battery technology.
Chief Financial Officer
Mr McInally has been a chartered accountant for 20 years working in both the profession and commerce. Glenn has held the positions of Manager, Senior Manager, Executive and Director at several Accounting practices before cofounding McVinish McInally SME Accountants Pty Ltd. Previously to becoming CFO, Mr McInally worked on various projects for Anteo over a span of 15 months
Chief Scientific Officer
Dr Joe Maeji has more than 20 years experience managing successful R&D projects in the biotechnology and life science industries. His focus has been on the commercialisation of products and technologies at the interface of chemistry and biology. He has significant experience in successfully securing funding for the development of new technologies, as well as in creating and securing extensive IP portfolios. Joe was a co-founder and founding CEO of the Bio-Layer Pty Ltd company that became Anteo Technologies.
Head of R&D
Dr Charlie Huang has more than 20 years experience in multi-discipline research and development. He has demonstrated scientific expertise in protein engineering, molecular biology, enzyme kinetics, drug discovery, bio-conjugation, bio-separation, immunoassay development, rapid and point of care diagnostics and nano-biotechnology. He also has significant commercial expertise in project management, technology analysis, licensing and intellectual proprieties management.